Wordt geladen...
OnabotulinumtoxinA in the treatment of refractory chronic cluster headache
BACKGROUND: Cluster headache (CH) is a clinically well-defined primary headache disorder, approximately 20% of cluster headache sufferers experience recurrent attacks without periods of significant remission. For the treatment of chronic cluster headache (CCH) only limited therapeutic options are av...
Bewaard in:
| Gepubliceerd in: | J Headache Pain |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Milan
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006000/ https://ncbi.nlm.nih.gov/pubmed/29915913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0874-y |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|